RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      The Behçet’s Disease Quality of Life: Reliability and Validity of the Korean Version

      한글로보기

      https://www.riss.kr/link?id=A101616964

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The Behçet’s Disease Quality of Life (BD-QoL) is a BD-specific measure developed in the UK. The aim of this study was to adapt the BD-QoL for use in Korea. Patients and Methods: The translation was based on the guidelines for cross-cultural adaptation. A total of 201 Korean patients with BD participated in this study. To evaluate the psychometric properties, internal consistency and test-retest reliability were used. Factor analysis was performed to examine the construct validity. To provide further evidence for validity, the correlation of BD-QoL with the Clinical Activity Form for Korean Patients with BD (BDCAF-K) and the Center for Epidemiologic Studies-Depression (CES-D) scales was assessed. Results: The Korean version had high internal consistency (Cronbach’s alpha, 0.93) and test-retest reliability (r=0.835). Factor analysis of the questionnaire revealed one interpretable factor as a general health-related quality of life factor. The Korean version significantly correlated with scores of CES-D (r=0.749, p=0.000), self- rating scale of well-being over the past 28 days (r=0.446, p=0.000), and BDCAF-K score (r=0.502, p=0.000). Conclusion: Adaptation of the BD-QoL for use in Korea was successful. Together with the BDCAF-K, it may be a valuable tool for assessing the influence of interventions in BD patients and outcome in clinical trials.
      번역하기

      Purpose: The Behçet’s Disease Quality of Life (BD-QoL) is a BD-specific measure developed in the UK. The aim of this study was to adapt the BD-QoL for use in Korea. Patients and Methods: The translation was based on the guidelines for cross-cultura...

      Purpose: The Behçet’s Disease Quality of Life (BD-QoL) is a BD-specific measure developed in the UK. The aim of this study was to adapt the BD-QoL for use in Korea. Patients and Methods: The translation was based on the guidelines for cross-cultural adaptation. A total of 201 Korean patients with BD participated in this study. To evaluate the psychometric properties, internal consistency and test-retest reliability were used. Factor analysis was performed to examine the construct validity. To provide further evidence for validity, the correlation of BD-QoL with the Clinical Activity Form for Korean Patients with BD (BDCAF-K) and the Center for Epidemiologic Studies-Depression (CES-D) scales was assessed. Results: The Korean version had high internal consistency (Cronbach’s alpha, 0.93) and test-retest reliability (r=0.835). Factor analysis of the questionnaire revealed one interpretable factor as a general health-related quality of life factor. The Korean version significantly correlated with scores of CES-D (r=0.749, p=0.000), self- rating scale of well-being over the past 28 days (r=0.446, p=0.000), and BDCAF-K score (r=0.502, p=0.000). Conclusion: Adaptation of the BD-QoL for use in Korea was successful. Together with the BDCAF-K, it may be a valuable tool for assessing the influence of interventions in BD patients and outcome in clinical trials.

      더보기

      참고문헌 (Reference)

      1 Cho MJ, "Use of the Center for Epidemiologic Studies Depression (CES-D) Scale in Korea" 186 : 304-310, 1998

      2 Emery P, "Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantlyimproved health-related quality of life" 33 : 681-689, 2006

      3 Weissman MM, "Sex differences in rates of depression: cross-national perspectives" 29 : 77-84, 1993

      4 Blackford S, "Quality of life in Behçet’s syndrome: 335 patients surveyed" 136 : 293-, 1997

      5 Bodur H, "Quality of life and life satisfaction in patients with Behçet’s disease: relationship with disease activity" 25 : 329-333, 2006

      6 Mumcu G, "Oral health related quality of life is affected by disease activity in Behçet's disease" 12 : 145-151, 2006

      7 Erkan Alpsoy, "Mucocutaneous Lesions of Behcet's Disease" 연세대학교의과대학 48 (48): 573-585, 2007

      8 Hubley AM, "Injection Drug UseQuality of Life Scale (IDUQOL): a validation study" 3 : 43-, 2005

      9 Russell DW, "In search of underlying dimensions: The use (and abuse) of factor analysis in personality and social psychology bulletin" 28 : 1629-1646, 2002

      10 Beaton DE, "Guidelines for the process of cross-cultural adaptation of self-report measures" 25 : 3186-3191, 2000

      1 Cho MJ, "Use of the Center for Epidemiologic Studies Depression (CES-D) Scale in Korea" 186 : 304-310, 1998

      2 Emery P, "Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantlyimproved health-related quality of life" 33 : 681-689, 2006

      3 Weissman MM, "Sex differences in rates of depression: cross-national perspectives" 29 : 77-84, 1993

      4 Blackford S, "Quality of life in Behçet’s syndrome: 335 patients surveyed" 136 : 293-, 1997

      5 Bodur H, "Quality of life and life satisfaction in patients with Behçet’s disease: relationship with disease activity" 25 : 329-333, 2006

      6 Mumcu G, "Oral health related quality of life is affected by disease activity in Behçet's disease" 12 : 145-151, 2006

      7 Erkan Alpsoy, "Mucocutaneous Lesions of Behcet's Disease" 연세대학교의과대학 48 (48): 573-585, 2007

      8 Hubley AM, "Injection Drug UseQuality of Life Scale (IDUQOL): a validation study" 3 : 43-, 2005

      9 Russell DW, "In search of underlying dimensions: The use (and abuse) of factor analysis in personality and social psychology bulletin" 28 : 1629-1646, 2002

      10 Beaton DE, "Guidelines for the process of cross-cultural adaptation of self-report measures" 25 : 3186-3191, 2000

      11 DeVellis RF, "Factor analysis Scale development: Theory and applications (applied Social Research Methods)." Sage Publications 102-137, 2003

      12 Gilworth G, "Development of the BD-QoL: a quality of life measure specificto Behçet's disease" 31 : 931-937, 2004

      13 Lee ES, "Development of clinical activity form for Korean patients with Behçet's disease" 528 : 153-156, 2003

      14 International Study Group for Behçet's Disease (ISGBD), "Criteria for diagnosis of Behçet's disease" 335 : 1078-1080, 1990

      15 Bhakta BB, "Behçet’s disease: evaluation of a new instrument to measure clinical activity" 38 : 728-733, 1999

      16 Suzuki Kurokawa M, "Behçet’s disease" 4 : 10-20, 2004

      17 Gur A, "Arthropathy, quality of life, depression, and anxiety inBehçet’s disease: relationship between arthritis and these factors" 25 : 524-531, 2006

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼